IDIVAL announces a temporary labor contract in practices for the development of activities in the field of research and innovation manager in health sciences and technologies (GES-VAL).
The purpose of this program is to promote the professional practice and training of technicians in aspects related to research management: you will learn aspects related to monitoring and evaluation of actions to promote IDIVAL research, as well as internationalization and innovation activities in the field of health sciences and technologies. This program may be co-financed with ERDF funds.
The salary of the selected candidates will be the first year 75% and the second year 80% of the salary corresponding to the category of second cycle university graduate, which is € 24,317.35 gross. The internship contract that will have an initial duration of 12 months, counted from the date of incorporation, extendable for another 12 months, after evaluation of the activity of the contractor. The trial period will be two months.
The selected candidate will develop a tutored training itinerary, with periodic evaluations and presentation of a report at the end of the first annual year (in the last month of each year), with a report from their tutor, which must be positive for continued funding.
CANDIDATE REQUIREMENTS
a) Second cycle university graduates (official master or graduate).
The contract may be concluded with those who are in possession of the required university degree, provided that, on the date of publication of this call, no more than five years have elapsed, or seven, when the contract is concluded with a worker with a disability, from the completion of the studies to the beginning of the contract.
Along with the application, applicants must submit the following documentation:
a) Curriculum vitae in CVN format (FECYT full version), available at: https://cvn.fecyt.es/ and IDIVAL intranet.
b) Report on the proposal of the activities to be carried out by the candidate. It must collect the activities to be carried out by the candidate and include general references to the different IDIVAL support areas, with a more detailed description of those that adapt to the candidate's profile and interests: project area, training area and methodological support, clinical trials area, technological services area, innovation area and general services area. In summary, it consists of relating to their profile, the areas and topics they are interested in training, based on the information they may collect on the activity of the different areas of IDIVAL.
c) Copy of DNI. Copy of the valid passport, only in the case of foreign citizens not resident in Spanish territory.
d) Official academic certification of the studies carried out, with details of the subjects taken and the grades obtained, and, where appropriate, a copy of the academic title.
e) Documentary accreditation of the curricular merits provided (working life certificate, candidate's credentials, course certificates stating their duration, etc.), without which requirement they will not be taken into consideration.
SUBMISSION OF APPLICATIONS AND REQUIRED DOCUMENTATION
Applications will be submitted exclusively in formats specially designed for it. All applications will be submitted through the IDIVAL telematics platform, whose access is public through its website: www.idival.org
The deadline for submitting applications will be until May 12, 2021.
Publication in the BOC of April 9, 2021
More information in the IDIVAL Help Portal: IDIVAL Help Portal (link)
IDIVAL announces a temporary labor contract in practices for the development of activities in the field of research and innovation manager in health sciences and technologies (GES-VAL). The purpose of this program is to promote the professional practice and training of technicians in aspects related to research management: you will learn aspects related to monitoring […]
Next May (May 18th to 20th) the I Cantabria Health Congress is held, which is created as a forum that allows the exchange of good practices and dissemination of knowledge.
Internally, this Congress seeks to be a complementary space for other initiatives that are already being developed at the local level, such as the "Days of Exchange of Good Practices" in the Hospitals of Sierrallana and Tres Mares, and the "Days of Innovation and Development" at the "Marqués de Valdecilla" University Hospital and an opportunity for other Managements and other professions in our field. Externally, this Congress will be a space that allows us to establish synergies with our stakeholders.
The Congress will focus on the theme of Sustainable Development: "Health and Well-being for all at all ages".
"Ensuring healthy lives and promoting well-being for all at all ages is important for building prosperous societies"
Given the circumstances, the congress is held online. The registration period is open until next May 5.
Registration: https://congresosaludcantabria.com/inscripci%C3%B3n
At the following link you can access the Congress program: Program (link)
More information: https://congresosaludcantabria.com/
Next May (May 18th to 20th) the I Cantabria Health Congress is held, which is created as a forum that allows the exchange of good practices and dissemination of knowledge. Internally, this Congress seeks to be a complementary space for other initiatives that are already being developed at the local level, such as the "Days […]
The IDIVAL brand, an acronym for the Instituto de Investigación Marqués de Valdecilla, created in 2014, has been cited more than 20,000 times by the international biomedical literature, according to data recently obtained on the Web of Science platform.
According to these data, the more than 2,500 works published by the authors who have the IDIVAL brand in their affiliation (exclusive brand worldwide in our region, linked to the Valdecilla brand) have been referenced more than 20,000 times by international literature, signal clear of the rapid growth in prestige and the impact of the Instituto de Investigación Marqués de Valdecilla. These citations grow year by year, significantly and in 2020 they have exceeded 7,000 citations, with an average of 8.4 citations per job and an H index of 58). Currently more than 21 works have received more than 100 citations in the international literature. These are indicators of the impact and visibility of scientific activity.
The first work published with the Valdecilla brand in 2014 was the following: Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. Biomed Res Int. 2014;2014:860651.
Despite its youth, the IDIVAL brand is not only a consolidated brand in our region, it is also known internationally, as evidenced by data from the scientific literature.
The calculation of the citations has been carried out using the descriptor "IDIVAL" in the "address" field of the search engine of the Web of Science (WOS) platform.
The most cited work since IDIVAL was established in 2014 has been the result of an international collaboration that reviews the deposit of cerebral amyloid, implicated in Alzheimer's disease, in the general population. Jansen WJ, Ossenkoppele R, Knol DL, …Sanchez-Juan P, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015 May 19;313(19):1924-38.
The IDIVAL brand, an acronym for the Instituto de Investigación Marqués de Valdecilla, created in 2014, has been cited more than 20,000 times by the international biomedical literature, according to data recently obtained on the Web of Science platform. According to these data, the more than 2,500 works published by the authors who have the […]
On April 14, the next session of the Progress Reports Valdecilla Program will take place with presentations by Gabriela Veiga Fernández and David Salcines Cuevas.
A new pathophysiological approach to the compression and management of sclerodegenerative aortic stenosis
SPEAKER: Gabriela Veiga Fernández
Gabriela Veiga Fernández obtained her Bachelor's degree in Medicine and Surgery at the University of Oviedo in 2009 and her Bachelor's Degree in Medicine in 2010. Later, after taking the MIR exam, she completed the 5-year residency in Cardiology at the international HUMV, obtaining the title of Cardiologist in 2015. During this period, she spent 4 months at the Institut universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) in the area of Interventional Cardiology.
After completing his residency and until now he works as a FEA of Cardiology at the HUMV having subspecialized and accredited in Hemodynamics and Interventional Cardiology. In addition, she is a clinical simulation instructor at the Center for Medical Simulation in Boston developing teaching courses at the Valdecilla Virtual Hospital.
During these years he has completed several Masters in Clinical Research Methodology, Thromboembolic and Hemodynamic Disease and Endovascular Interventionism. In addition, it participates annually in congresses of its specialty both nationally and internationally with the presentation of research works in its field, having more than 20 articles in prestigious journals indexed in JRC.
Collaborates in 2 NEXTVAL (IDIVAL) projects since 2017: “The “progressive” patient as a new clinical entity in patients with coronary atherosclerosis. Exploratory study on possible molecular substrates” and “Impact on the quality of life and functionality of patients with percutaneous aortic valve implantation versus surgical aortic valve replacement”.
3 years ago he joined the Doctorate program in Medicine and Health Sciences at the University of Cantabria.
New nanovaccines against intracellular pathogens
SPEAKER: David Salcines Cuevas
David Salcines Cuevas obtained his degree as a graduate in Biotechnology in 2015 from the University of Zaragoza. In 2017 he completed a Master in Biology and Molecular Biomedicine from the University of Cantabria.
Since 2018 he has been working as a research support technician in the Oncology and Nanovaccines Group at the Marqués de Valdecilla Research Institute (IDIVAL).
He is co-author of several scientific articles of impact and in the patent "Gold glyconanoparticles conjugated to peptide 1-15 of glyceraldehyde-3-phosphate-dehydrogenase as bacterial vaccines" since 2019.
Due to the current situation, the session will be given in virtual format through the zoom platform. Registration is mandatory to obtain the link to access the session.
Click here for Registration and registration
The session will begin at 14:00. The talk of each speaker will be about 20 minutes followed by a small debate.
Any questions or clarification can be contacted at projects1@idival.org
On April 14, the next session of the Progress Reports Valdecilla Program will take place with presentations by Gabriela Veiga Fernández and David Salcines Cuevas. A new pathophysiological approach to the compression and management of sclerodegenerative aortic stenosis SPEAKER: Gabriela Veiga Fernández Gabriela Veiga Fernández obtained her Bachelor's degree in Medicine and Surgery at […]
On March 17, the following session of the "IDIVAL Group Synergies" outreach program will be held. The main objective of this cycle of sessions is to improve the knowledge of the priority activities and lines of research of the groups, which favor the creation of synergies for new alliances in collaborative work.
The speaker for this session will be Dr. Rosa Ayesa Arriola, principal investigator of the IDIVAL Psychiatry Research Group, will give us a session entitled "The future of cognitive and functional capacity assessments: multicenter project for adaptation and validation of a battery of Digital neuropsychological evaluation and a virtual reality test ".
Rosa Ayesa is Senior Researcher at the Valdecilla Research Institute (IDIVAL). She earned her degree in Psychology in 2004 and her master's degree in Neuropsychology in 2006 from National University of Distance Education (UNED), and received her Ph.D. in 2010 from the University of Cantabria (UC). She was a visiting fellow at Olin Neuropsychiatry Research Center at Hartford, Yale University USA (2011), Institute of Psychiatry, Kings College London UK (2013), and Brain Center Rudolf Magnus, Utrecht University Netherlands (2015 and 2016).
Since 2007 she develops her work within the Program of Attention to the Initial Phases of Psychosis (PAFIP) at the Marqués de Valdecilla University Hospital, Department of Psychiatry, as neuropsychologist, focused on the study of cognitive functions and functional outcome in the first episode of psychosis patients. She is a member of the Research Network of Mental Health (CIBERSAM) since 2009, where she is currently conducting her research. She is Principal Investigator in the ISCIII funded project 10PAFIP neurocognition: Long-term longitudinal study (10 years) of cognitive functioning in patients with psychosis of schizophrenia spectrum disorders.
Her merits in research and teaching have allowed her to get ANECA accreditation in 2015. Her academic trajectory has been developed as associate professor in the Degree of Psychology at the UNED (Bergara 2008 to 2015) and in the Degree of Physiotherapy at the Gimbernat School of Physiotherapy University UC. She has been the director of five master thesis related to her research lines within the Master of Initiation to Mental Health Research (CIBERSAM-UC). Currently she is the supervisor of three Ph.D. projects in the Doctorate in Medicine and Health Sciences program at the UC.
Dr. Ayesa has an H-Index of 14 (Google Scholar) having published over 50 peer-reviewed articles and book chapters including articles in high-impact journals.
The session will begin at 2:00 p.m. and will last 45 minutes and will be taught through the zoom platform, prior registration being necessary.
Previous registration (link)
We encourage everyone to participate. Any questions or clarification can be contacted at projectos1@idival.org
On March 17, the following session of the "IDIVAL Group Synergies" outreach program will be held. The main objective of this cycle of sessions is to improve the knowledge of the priority activities and lines of research of the groups, which favor the creation of synergies for new alliances in collaborative work. The speaker for […]
IDIVAL announces the NEXT-VAL (NEXT generation VALdecilla) program within the call for the Valdecilla 2021 Biosanitary Revitalization Plan, aimed at emerging researchers. This call, which promotes young talent and wants to facilitate the first leap for researchers to obtain competitive funding, tries to cover a gap that has increased in recent years due to greater competitiveness in accessing funding for research projects.
Potential beneficiaries as main researchers of the NEXT-VAL grants are those people with a labor, official or statutory relationship with the Cantabria Public Health System, with the University of Cantabria as a professor linked to healthcare activity or, failing that, as staff of a IDIVAL research group.
According to the criterion of emerging researcher of the Strategic Action in Health of the Carlos III Health Institute, the principal investigators must not be more than forty-five years old and have never accessed funding as principal investigator in a project obtained through a call for national or international competitive grants, or in the IDIVAL Next-Val, Prim-val, or Inn-Val calls. Training specialists are excluded.
NEXT-VAL research projects will have a minimum duration of one year and a maximum of two. The maximum amount to be awarded per project is €25,000. The funding granted may fully or partially finance the project for which the grant is requested. The maximum allowable travel expense in the execution of each project will be € 3,000.
Required documentation: (see bases)
– Standardized CVA of each of the members of the research team.
– Report of the research project.
Application evaluation:
a) Assessment of the research team. It will be valued up to a maximum of 30 points: scientific-technical history; previous results obtained in the scope of the proposal and complementarity of the team. The participation of residents of the mentoring program or post-MIR Valdecilla contracts in the research team, the belonging of the main researcher to Primary Care or Nursing or to other areas underrepresented in IDIVAL research will be especially valued.
b) Project evaluation. A maximum of 70 points will be valued: quality, feasibility, relevance, translational interest, applicability of the project, capacity of the project to generate improvements in the knowledge of the bases of pathogenesis, in prevention, diagnosis, treatment of diseases, safety of the patient. Alignment with the needs and interests of the Public Health System of Cantabria and potential socioeconomic impact of the project. Those studies carried out on patients will be especially valued.
Application deadlines: February 15 to March 15, 2020.
Note: The execution of these funds will be carried out in accordance with the IDIVAL Project Management Instructions.
More detailed information on the call in the following BOC link: Official Gazette of Cantabria (download pdf)
More information on the IDIVAL aid portal: IDIVAL aid portal (link)
IDIVAL announces the NEXT-VAL (NEXT generation VALdecilla) program within the call for the Valdecilla 2021 Biosanitary Revitalization Plan, aimed at emerging researchers. This call, which promotes young talent and wants to facilitate the first leap for researchers to obtain competitive funding, tries to cover a gap that has increased in recent years due to greater […]
The next session of Progress Reports Valdecilla Program Will be on March 10, with the presentations of Sara Barrio Martínez and Javier Menéndez Menéndez.
The relevance of baseline emotion regulation skills in cognitive-behavioural therapy for emotional disorders
Speaker: Sara Barrio Martínez
Sara Barrio Martínez obtained her Graduate degree in Psychology in 2018 at the European University of the Atlantic. During 2019, she began to collaborate in a research project on the phenomenological study of suicide in the Department of Psychology of the University of Oviedo.
At the same time, between 2018-2020 she obtained her Master in General Health Psychology at the University of Oviedo. In 2020, she began her doctoral studies in Medicine and Health Sciences at the University of Cantabria.
She is currently a Research Support Technician in the Psychiatry Research Group of the Marqués de Valdecilla Research Institute (IDIVAL).
Melatonin as modulator of the molecular changes induced by chemotherapy on breast cancer
Speaker: Javier Menéndez Menéndez
Javier Menéndez Menéndez obtained his Graduate degree in Biology at the University of Oviedo in 2015 with the presentation of the Final Degree Project entitled "Sensitizing effects of melatonin in breast cancer treatments" carried out in the research group " Melatonin and breast cancer” of the Department of Physiology and Pharmacology of the Faculty of Medicine, University of Cantabria. After that, he continued working in that group and in 2016 he completed the interuniversity Master in Molecular Biology and Biomedicine at the University of Cantabria and the University of the Basque Country, with the preparation of a Master's Thesis entitled “Sensitizing effects of melatonin on docetaxel treatment in MCF-7 breast cancer cells”.
Next, he joined the Doctorate program in Molecular Biology and Biomedicine, which he completed in 2021 with the presentation of the Doctoral Thesis entitled “Melatonin as a modulator of the molecular changes induced by radiotherapy and chemotherapy in breast cance” Rated Cum Laude.
Throughout these years, Javier has participated in two research projects, has published 11 articles in prestigious journals indexed in JRC and has participated in 9 scientific conferences. In addition, he has made an international stay of three months in the research group "Cell signaling and proteomics" of the Barts Cancer Institute of Queen Mary University of London.
Due to the current situation, the session will be given in virtual format through the zoom platform. Registration is mandatory to obtain the link to access the session.
Click here for Registration and registration
The session will begin at 14:00. The talk of each speaker will be about 20 minutes followed by a small debate.
Any questions or clarification can be contacted at projects1@idival.org
The next session of Progress Reports Valdecilla Program Will be on March 10, with the presentations of Sara Barrio Martínez and Javier Menéndez Menéndez. The relevance of baseline emotion regulation skills in cognitive-behavioural therapy for emotional disorders Speaker: Sara Barrio Martínez Sara Barrio Martínez obtained her Graduate degree in Psychology in 2018 at the European […]
INTENCIVE Project, in which IDIVAL participates together with 5 European regions, continues working on its objective of improving the implementation of policies and programmes in terms of health technology innovation-driven and customer-oriented health services in the partner regions. Meetings and visits are regularly held with European partners in order to obtain an overview of the process of development of local policies towards e-Health in the participating regions.
On February 25, the third study visit and a thematic workshop were held online in the West-Transdanubian region, Hungary, in which the 3 most outstanding e-Health practices in Hungary were presented to stakeholders.
Good Practice 1: Alarm system for elderly in Szombathely, Hungary
Pálos Károly Social Service Centre and Children Welfare Service is working since 01.09.2010 in how to build in and maintain the alarm system for elderly in the city Szombathely. This is a 24hours service for seniors 65+ who are able to use the emergency call devise properly. The evidence of the success is proven not by the number of the emergency calls but by the feedback of the seniors that quality of their life and the sense of security were improved thus ensure to live at own home as long as possible.
The data gained from the above introduced alarm system for elderly was deeper analysed and led to the concept of Smart Senior Room which will be a complex microenvironment Integrating multiple elements of the smart room dedicated to senior people and formal, informal care providers. It focuses on both the individual and on the infrastructure, all elements showcased as a single platform. The Smart Senior Room is expected to open in the summer 2021.
Good Practice 2: IEM eHealth Solutions
IEM Ltd. introduced a new eHealth solution which organised medical services/monitoring in a unique way. It was explained how the company organize ICT solutions to give answer for the above-mentioned problems. The Hardware, Software, Coaching, Data management and Service package parts of the modular system were introduced in detail.
Good Practice 3: KÖSSZ app – Voluntary Service Application
In Hungary there is a regulation that each secondary student has to accomplish 50 hours community work. This application could be an option to ease the fulfilment of this task. This smart application is an online platform to support quality service for the involved participants. Using the app could lead to a win-win situation where the caregiver organisations which always suffer from lack of workforce can supported by the students in the fulfilment of non-professional work.
Likewise, a thematic workshop was held in which the following tools and initiatives that can influence e-health policies were presented:
The councillor of the City Szombathely introduced the ICC program and the Interreg Europe Policy Learning Platform Peer Review support which is mentoring the City of Szombathely to elaborate the development program (Szombathely2030) to strengthen a new industry, especially the health industry in the local ecosystem by attracting healthcare companies.
A network of digital health focused DIHs were introduced. The main goal of the network is to concretely support European relationships among local and regional technology focused intermediaries thus expanding their “service” potential to “end users” or “technology developers & testers”, as well as to facilitate technology transfer actions in the European health sector.
INTENCIVE Project, in which IDIVAL participates together with 5 European regions, continues working on its objective of improving the implementation of policies and programmes in terms of health technology innovation-driven and customer-oriented health services in the partner regions. Meetings and visits are regularly held with European partners in order to obtain an overview of the […]
On March 9, the UC-IDIVA Health Economics research group organizes the webinar 'The importance of the “where”, what do we know about the spatial behavior of COVID-19?' focused on the spatial facet of the pandemic. With a multiscale approach and on the basis of analyzes based on geotechnologies, this meeting will allow the exchange of experiences on the revealing investigations that are being carried out in Spain.
Webinar program:
The webinar is open to all audiences. Registrations at: https://forms.gle/m1Gx7QSb3TSBWE9c8
On March 9, the UC-IDIVA Health Economics research group organizes the webinar 'The importance of the “where”, what do we know about the spatial behavior of COVID-19?' focused on the spatial facet of the pandemic. With a multiscale approach and on the basis of analyzes based on geotechnologies, this meeting will allow the exchange of […]
Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journal of Hepatology.
Non-alcoholic steatohepatitis, characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people.
Unhealthy nutritional habits and dietary imbalances are recognized as the main cause of many diseases. Magnesium is widely distributed in both the plant and animal food supply. Most vegetables, legumes, peas, beans and nuts are rich in magnesium, as are some seafood and spices.
In recent years, there has been growing concern about defective magnesium intake in the general population. According to the National Health and Nutrition Examination Survey (NHANES), 79% of U.S. adults do not meet the recommended intake of this cation.
The study, led by Dr. Malu Martínez Chantar, Principal Investigator of the Liver Disease laboratory of (CIC bioGUNE -a member of the Basque Research & Technology Alliance BRTA- and CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD), and Dr. Jorge Simon, first author of the publication, has shown a higher expression of the CNNM4 protein in patients with non-alcoholic steatohepatitis. CNNM4 acts as a transporter of magnesium out of the liver, being responsible for the imbalance in the levels of this cation, that ends in the development of liver disease.
"These patients have an altered magnesium export machinery that increases the vulnerability of their liver to suffer inflammatory processes, development of fibrosis and fat deposition," explains Dr. Martínez Chantar. “This study also presents a novel therapeutic approach based on GalNac-siRNA technology that specifically targets the liver by modulating CNNM4 levels. The CNNM4 molecule developed from Silence Therapeutics’ proprietary mRNAi GOLD™ (GalNAc Oligonucleotide Discovery) Platform effectively protects from liver pathology in preclinical models of steatohepatitis.”
This molecule opens an unexplored therapeutic window in non-alcoholic fatty liver disease.
“The study underscores the importance of magnesium balance for supporting liver health. With insight into how this essential metal affects lipid metabolism at the cellular level, possible therapeutic targets for this and other liver pathologies start emerging,” says Daniela Buccella, associate professor of chemistry at New York University and a study co-author.
This work has had the collaboration of Dr. Javier Crespo, head of the Clinical and Translational Research Group in Digestive Diseases, and Dr. Paula Iruzubieta, collaborator of the same group. Likewise, Dr. Alfonso Martínez (CIC bioGUNE); Dr. Patricia Aspichueta and Dr. César Martín from the University of the Basque Country / Euskal Herriko Unibertsitatea (UPV / EHU); Dr. Daniela Buccella from New York University; Dr. Guadalupe Sabio (Carlos III National Center for Cardiovascular Research Foundation); Dr. Franz Martin from CABIMER, Pablo de Olavide University, CIBERDEM; Dr. Ute Schaeper (Silence Therapeutics) and a consortium of national researchers have been published in the international Journal of Hepatology.
Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journal of Hepatology. Non-alcoholic steatohepatitis, characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people. Unhealthy […]
